NeoDynamics

Introducing NeoNavia® – The next generation of tissue sampling. With patented pulse technology to ensure optimal needle control and maximum tissue yield. #neonavia #biopsy

As a consequence of the cost reduction plan announced in November, Aaron Wong, CFO will be leaving NeoDynamics by end May 2024. neodynamics.com/en-gb/press-…

Update on NeoDynamics’ financial situation - The Board and Management of NeoDynamics have secured short-term financing. neodynamics.com/en-gb/press-…

NeoDynamics receives approximately SEK 0.5 million through the exercise of warrants of series T02. Read press release: neodynamics.com/en-gb/press-…

Our US Team is present at the Radiological Society of North America's (#RSNA2023 ) 109th Scientific Assembly and Annual Meeting in Chicago to show off our #NeoNavia biopsy system!

NeoDynamics Interim Report Jan-Sep 2023. Read press release here: neodynamics.com/en-gb/press-…

The Board of Directors of NeoDynamics has assessed the current financial situation of the company as critical and is in discussions to secure short and long-term financing. Read press release here: neodynamics.com/en-gb/press-…

Change to Financial Calendar 2023 - NeoDynamics will release its Interim Report for January-September 2023 on 28 November 2023. neodynamics.com/en-gb/press-…

NeoDynamics will release its Interim Report for January-September 2023 on 27 November 2023. Press release: neodynamics.com/en-gb/press-…

The exercise period for NeoDynamics warrants of series TO2 Begins today. Press release: neodynamics.com/en-gb/press-…

Watch our CFO Aaron Wong present at Redeye Medtech & Diagnostics Event (26 September, 2023). redeye.se/video/event-presen…

#NeoDynamics CEO Anna Eriksrud gives an interview with Redeye, providing a status update on the commercialisation and development of the American market. neodynamics.com/en-gb/press-…

Sista dag för handel med BTU i NeoDynamics är den 20 september. Läs pressmeddelandet här: neodynamics.com/sv-se/press-…

NeoDynamics announces outcome of rights issue neodynamics.com/en-gb/press-…

NeoDynamics publishes supplement to prospectus. neodynamics.com/en-gb/press-…

NeoDynamics reaches an important milestone in the US with the receipt of its first commercial order for #NeoNavia. Read the press release here: neodynamics.com/en-gb/press-…

The subscription period in #NeoDynamics rights issue begins today. neodynamics.com/en-gb/press-…

NeoDynamics Interim Report Jan-June 2023 shows promising Feedback from the US. neodynamics.com/en-gb/press-…

NeoDynamics publishes a prospectus in connection with the forthcoming rights issue. neodynamics.com/en-gb/press-…

Takeaways from the presentations of the PULSE study at the Annual Congress of the German Society of Senology in Munich: - high success rate and low rate of adverse - high control and precision during needle insertion - was able to take multiple samples with a single insertion

CEO Anna Eriksrud makes a short presentation of #NeoDynamics and answers questions regarding the rights issue in an interview in collaboration with Uddaaktier on Monday, July 3rd, at 7 p.m. neodynamics.com/en-gb/press-…